Related Experiment Videos
Fulminant nonocclusive mesenteric ischemia developing just after esophagectomy
N Hokamura1, H Kato, H Watanabe
1Department of Surgery, National Cancer Center Hospital, Tokyo, Japan. nhokamur@gan2.res.ncc.go.jp
Hepato-Gastroenterology
|November 27, 1999
Summary
Nonocclusive mesenteric ischemia (NOMI) after esophagectomy presents a rapid, severe clinical course with high mortality. Post-operative NOMI requires distinct recognition from spontaneous cases due to unique risk factors and challenges.
Area of Science:
- Gastroenterology
- Surgical Oncology
- Critical Care Medicine
Background:
- Nonocclusive mesenteric ischemia (NOMI) is a severe intestinal condition with high mortality.
- NOMI is poorly understood, often leading to infarction, sepsis, and death.
Observation:
- Three cases of NOMI were observed following esophagectomy at our institution.
- Post-operative NOMI after major surgery appears to have a more aggressive progression and higher mortality rate than spontaneous NOMI.
Findings:
- A significant fluid shift between intravascular and extravascular spaces during/after surgery is implicated in post-operative NOMI.
- Diagnosing and treating NOMI post-major surgery presents considerable difficulties.
Implications:
- NOMI following esophagectomy warrants specific consideration and potentially distinct management strategies.
- Further research is needed to elucidate the mechanisms and optimize treatment for post-operative NOMI.